![Leah Monteiro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Leah Monteiro worked as Senior Director-Communications & IR at KalVista Pharmaceuticals, Inc. from 2016 to 2021.
The career history includes roles as Vice President-Investor Relations at DURECT Corp., Senior Manager-Investor Relations at Genzyme Corp., Manager-Corporate Communications at Sesen Bio, Inc., and Vice President-Investor Relations & Communications at Solid Biosciences, Inc. from 2023 to 2024.
Former jobs include positions at KalVista Pharmaceuticals, Inc., DURECT Corp., Genzyme Corp., Sesen Bio, Inc., and Solid Biosciences, Inc.
Antiguos cargos conocidos de Leah Monteiro.
| Empresas | Cargo | Fin |
|---|---|---|
| SOLID BIOSCIENCES INC. | Contacto de Relaciones con Inversores | 30/04/2024 |
| KALVISTA PHARMA | Contacto de Relaciones con Inversores | 01/12/2021 |
| CARISMA THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/07/2016 |
| DURECT | Contacto de Relaciones con Inversores | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Contacto de Relaciones con Inversores | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
16
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
- Bolsa de valores
- Insiders
- Leah Monteiro
